CEN Biotech, Inc.
CENBF
$0.0001
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 1.37M | 1.51M | 967.20K | 626.90K | 272.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37M | 1.51M | 967.20K | 626.90K | 272.20K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.37M | 1.51M | 967.20K | 626.90K | 272.20K |
| SG&A Expenses | 2.67M | 2.97M | 18.39M | 18.25M | 17.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.67M | 2.97M | 18.39M | 18.25M | 17.88M |
| Operating Income | -1.30M | -1.46M | -17.42M | -17.63M | -17.61M |
| Income Before Tax | -3.11M | -3.43M | -18.58M | -18.94M | 2.30M |
| Income Tax Expenses | -36.40K | -36.40K | -36.40K | -36.40K | -- |
| Earnings from Continuing Operations | -3.08 | -3.39 | -18.54 | -18.90 | 2.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.08M | -3.39M | -18.54M | -18.90M | 2.30M |
| EBIT | -1.30M | -1.46M | -17.42M | -17.63M | -17.61M |
| EBITDA | -870.90K | -1.09M | -16.97M | -17.16M | -17.15M |
| EPS Basic | -0.06 | -0.07 | -0.44 | -0.46 | 0.28 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.26 | -0.27 | -0.31 |
| EPS Diluted | -0.06 | -0.07 | -0.44 | -0.46 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.26 | -0.27 | -0.29 |
| Average Basic Shares Outstanding | 221.54M | 204.89M | 184.15M | 169.31M | 143.05M |
| Average Diluted Shares Outstanding | 221.54M | 204.89M | 184.15M | 169.31M | 164.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
